Topiramate versus amitriptyline in migraine prevention: A double blind randomized study

被引：0
|
作者：
Rodriguez-Leyva, Ildefonso
Rivera-Lara, Angelica L.
Hernandez-Sierra, Juan Francisco
Mandebille, Peter B.
Aguilar, Martin Sanchez
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A477 / A477
页数：1
相关论文
共 50 条
  • [1] A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine
    Keskinbora, Kader
    Aydinli, Isik
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (10) : 979 - 984
  • [2] Topiramate versus amitriptyline for migraine prophylaxis: a multicenter, randomized, double-blind, parallel treatment group trial
    Dodick, D.
    Silberstein, S.
    Freitag, F.
    Ruoff, G.
    Banks, J.
    Saper, J.
    Xiang, J.
    Finlayson, G.
    Biondi, D.
    Greenberg, S. J.
    Hulihan, J. F.
    CEPHALALGIA, 2006, 26 (11) : 1373 - 1373
  • [3] Topiramate versus amitriptyline for migraine prophylaxis: A multicenter, randomized, double-blind, parallel treatment group trial
    Dodick, David
    Silberstein, Stephen
    Freitag, Frederick
    Ruoff, Gary
    Banks, James
    Saper, Joel
    Xiang, Jim
    Finlayson, Gar
    Rupnow, Marcia
    Biondi, David
    Greenberg, Steven
    Hulihan, Joseph
    NEUROLOGY, 2007, 68 (12) : A367 - A367
  • [4] Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study
    Bulut, S
    Berilgen, MS
    Baran, A
    Tekatas, A
    Atmaca, M
    Mungen, B
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 107 (01) : 44 - 48
  • [5] Topiramate versus propranolol for prevention of chronic migraine: A randomized double-blind controlled trial (TOP-PRO study)
    Chowdhury, Debashish
    Bansal, Luv
    Duggal, Ashish
    Datta, Debabrata
    Koul, Arun
    Mundra, Ankit
    Krishnan, Anand
    Gupta, Anu
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [6] TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine
    Chowdhury, Debashish
    Bansal, Luv
    Duggal, Ashish
    Datta, Debabrata
    Mundra, Ankit
    Krishnan, Anand
    Koul, Arun
    Gupta, Anu
    CEPHALALGIA, 2022, 42 (4-5) : 396 - 408
  • [7] Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
    Dodick, David W.
    Freitag, Fred
    Banks, James
    Saper, Joel
    Xiang, Jim
    Rupnow, Marcia
    Biondi, David
    Greenberg, Steven J.
    Hulihan, Joseph
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 542 - 559
  • [8] Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial
    Mohammadianinejad, Seyed Ehsan
    Abbasi, Vahid
    Sajedi, Seyed Aidin
    Majdinasab, Nastaran
    Abdollahi, Fahimeh
    Hajmanouchehri, Reza
    Faraji, Asal
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (04) : 174 - 177
  • [9] Topiramate in migraine prevention: A double-blind, placebo-controlled study
    Storey, JR
    Calder, CS
    Hart, DE
    Potter, DL
    HEADACHE, 2001, 41 (10): : 968 - 975
  • [10] Topiramate for migraine prevention: a randomized, double-blind, placebo-controlled, multiple-dose study
    Brandes, J
    Neto, W
    Jacobs, D
    Bhattacharaya, S
    CEPHALALGIA, 2003, 23 (07) : 694 - 694
12345